COMMON IMATINIB: A COST-EFFECTIVE OPTION?

The arrival of off-brand imatinib represents a substantial opportunity for patients battling CML and other illnesses. Original brand-name imatinib, branded as Gleevec, carries a high price label, frequently causing accessibility for some individuals. Off-brand versions, usually manufactured by va